# Idacorp Inc: financial statements, quarterly

IDA · NYSE · CIK 1057877 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ida.md) · [Financials](/companies/ida/financials.md) · [Filings](/companies/ida/filings.md) · [Insiders](/companies/ida/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ida/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [385](/filings/0001057877-24-000041.md) | [497](/filings/0001057877-24-000047.md) | [372 d](/filings/0001057877-26-000028.md) | [418](/filings/0001057877-25-000037.md) | [443](/filings/0001057877-25-000067.md) | [532](/filings/0001057877-25-000082.md) | [376 d](/filings/0001057877-26-000028.md) | [411](/filings/0001057877-25-000037.md) | [449](/filings/0001057877-25-000067.md) | [526](/filings/0001057877-26-000137.md) | [360 d](/filings/0001057877-26-000028.md) | [615](/filings/0001057877-26-000137.md) |
| Operating income | $m | [82.3](/filings/0001057877-24-000041.md) | [126](/filings/0001057877-24-000047.md) | [36.8 d](/filings/0001057877-26-000028.md) | [49.6](/filings/0001057877-25-000037.md) | [103](/filings/0001057877-25-000067.md) | [134](/filings/0001057877-25-000082.md) | [41.3 d](/filings/0001057877-26-000028.md) | [54.9](/filings/0001057877-25-000037.md) | [101](/filings/0001057877-25-000067.md) | [145](/filings/0001057877-26-000137.md) | [53.7 d](/filings/0001057877-26-000028.md) | [179](/filings/0001057877-26-000137.md) |
| Interest expense | $m | not reported | not reported | not reported | [32.8](/filings/0001057877-25-000037.md) | [32.5](/filings/0001057877-25-000067.md) | [34.1](/filings/0001057877-25-000082.md) | [36.4 d](/filings/0001057877-26-000028.md) | [37.0](/filings/0001057877-25-000037.md) | [42.5](/filings/0001057877-25-000067.md) | [44.9](/filings/0001057877-26-000137.md) | [43.8 d](/filings/0001057877-26-000028.md) | [49.5](/filings/0001057877-26-000137.md) |
| Income tax | $m | [8.1](/filings/0001057877-24-000041.md) | [13.8](/filings/0001057877-24-000047.md) | [(1.7) d](/filings/0001057877-26-000028.md) | [(5.5)](/filings/0001057877-25-000037.md) | [8.1](/filings/0001057877-25-000067.md) | [16.4](/filings/0001057877-25-000082.md) | [(3.8) d](/filings/0001057877-26-000028.md) | [(12.5)](/filings/0001057877-25-000037.md) | [(6.7)](/filings/0001057877-25-000067.md) | [7.7](/filings/0001057877-26-000137.md) | [(2.3) d](/filings/0001057877-26-000028.md) | [3.0](/filings/0001057877-26-000137.md) |
| Net income | $m | [68.6](/filings/0001057877-24-000041.md) | [105](/filings/0001057877-24-000047.md) | [31.3 d](/filings/0001057877-26-000028.md) | [48.2](/filings/0001057877-25-000037.md) | [89.5](/filings/0001057877-25-000067.md) | [114](/filings/0001057877-25-000082.md) | [37.9 d](/filings/0001057877-26-000028.md) | [59.6](/filings/0001057877-25-000037.md) | [95.8](/filings/0001057877-25-000067.md) | [124](/filings/0001057877-26-000137.md) | [43.6 d](/filings/0001057877-26-000028.md) | [160](/filings/0001057877-26-000137.md) |
| Diluted EPS | $ per share | [1.35](/filings/0001057877-24-000041.md) | [2.07](/filings/0001057877-24-000047.md) | not reported | [0.95](/filings/0001057877-25-000037.md) | [1.71](/filings/0001057877-25-000067.md) | [2.12](/filings/0001057877-25-000082.md) | not reported | [1.10](/filings/0001057877-25-000037.md) | [1.76](/filings/0001057877-25-000067.md) | [2.26](/filings/0001057877-26-000137.md) | not reported | [2.73](/filings/0001057877-26-000137.md) |
| Basic EPS | $ per share | [1.35](/filings/0001057877-24-000041.md) | [2.08](/filings/0001057877-24-000047.md) | not reported | [0.95](/filings/0001057877-25-000037.md) | [1.72](/filings/0001057877-25-000067.md) | [2.13](/filings/0001057877-25-000082.md) | not reported | [1.10](/filings/0001057877-25-000037.md) | [1.77](/filings/0001057877-25-000067.md) | [2.30](/filings/0001057877-26-000137.md) | not reported | [2.78](/filings/0001057877-26-000137.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.1](/filings/0001057877-23-000045.md) | [0.4](/filings/0001057877-23-000059.md) | [0.3](/filings/0001057877-25-000014.md) | [0.2](/filings/0001057877-24-000027.md) | [0.2](/filings/0001057877-24-000041.md) | [0.4](/filings/0001057877-24-000047.md) | [0.4](/filings/0001057877-26-000028.md) | [0.6](/filings/0001057877-25-000037.md) | [0.5](/filings/0001057877-25-000067.md) | [0.3](/filings/0001057877-25-000082.md) | [0.2](/filings/0001057877-26-000137.md) | [0.2](/filings/0001057877-26-000137.md) |
| Current assets | $bn | [0.7](/filings/0001057877-23-000045.md) | [1.0](/filings/0001057877-23-000059.md) | [1.0](/filings/0001057877-25-000014.md) | [0.8](/filings/0001057877-24-000027.md) | [0.8](/filings/0001057877-24-000041.md) | [1.0](/filings/0001057877-24-000047.md) | [1.0](/filings/0001057877-26-000028.md) | [1.2](/filings/0001057877-25-000037.md) | [1.1](/filings/0001057877-25-000067.md) | [1.0](/filings/0001057877-25-000082.md) | [0.8](/filings/0001057877-26-000137.md) | [1.1](/filings/0001057877-26-000137.md) |
| Total assets | $bn | [7.8](/filings/0001057877-23-000045.md) | [8.3](/filings/0001057877-23-000059.md) | [8.5](/filings/0001057877-26-000028.md) | [8.3](/filings/0001057877-24-000027.md) | [8.7](/filings/0001057877-24-000041.md) | [9.1](/filings/0001057877-24-000047.md) | [9.2](/filings/0001057877-26-000028.md) | [9.6](/filings/0001057877-25-000037.md) | [9.9](/filings/0001057877-25-000067.md) | [10.1](/filings/0001057877-25-000082.md) | [10.2](/filings/0001057877-26-000137.md) | [11.4](/filings/0001057877-26-000137.md) |
| Current liabilities | $bn | [0.5](/filings/0001057877-23-000045.md) | [0.5](/filings/0001057877-23-000059.md) | [0.6](/filings/0001057877-25-000014.md) | [0.5](/filings/0001057877-24-000027.md) | [0.5](/filings/0001057877-24-000041.md) | [0.6](/filings/0001057877-24-000047.md) | [0.7](/filings/0001057877-26-000028.md) | [0.7](/filings/0001057877-25-000037.md) | [0.7](/filings/0001057877-25-000067.md) | [0.9](/filings/0001057877-25-000082.md) | [0.9](/filings/0001057877-26-000137.md) | [0.9](/filings/0001057877-26-000137.md) |
| Long-term debt | $bn | [2.5](/filings/0001057877-23-000045.md) | [2.8](/filings/0001057877-23-000059.md) | [2.8](/filings/0001057877-25-000014.md) | [2.8](/filings/0001057877-24-000027.md) | [2.8](/filings/0001057877-24-000041.md) | [3.1](/filings/0001057877-24-000047.md) | [3.1](/filings/0001057877-26-000028.md) | [3.4](/filings/0001057877-25-000037.md) | [3.4](/filings/0001057877-25-000067.md) | [3.3](/filings/0001057877-25-000082.md) | [3.3](/filings/0001057877-26-000137.md) | [3.9](/filings/0001057877-26-000137.md) |
| Current portion of debt | $bn | not reported | not reported | [0.0](/filings/0001057877-25-000014.md) | [0.0](/filings/0001057877-24-000027.md) | [0.0](/filings/0001057877-24-000041.md) | [0.1](/filings/0001057877-24-000047.md) | [0.0](/filings/0001057877-26-000028.md) | [0.0](/filings/0001057877-25-000037.md) | [0.0](/filings/0001057877-25-000067.md) | [0.1](/filings/0001057877-25-000082.md) | [0.1](/filings/0001057877-26-000137.md) | [0.0](/filings/0001057877-26-000137.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [2.9](/filings/0001057877-23-000045.md) | [2.9](/filings/0001057877-24-000047.md) | [2.9](/filings/0001057877-26-000028.md) | [2.9](/filings/0001057877-25-000037.md) | [3.2](/filings/0001057877-25-000067.md) | [3.3](/filings/0001057877-25-000082.md) | [3.3](/filings/0001057877-26-000028.md) | [3.3](/filings/0001057877-25-000037.md) | [3.4](/filings/0001057877-25-000067.md) | [3.5](/filings/0001057877-26-000137.md) | [3.6](/filings/0001057877-26-000137.md) | [4.1](/filings/0001057877-26-000137.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(90.4)](/filings/0001057877-24-000027.md) | [97.2 d](/filings/0001057877-24-000041.md) | [155 d](/filings/0001057877-24-000047.md) | [105 d](/filings/0001057877-26-000028.md) | [110](/filings/0001057877-25-000037.md) | [146 d](/filings/0001057877-25-000067.md) | [202 d](/filings/0001057877-25-000082.md) | [136 d](/filings/0001057877-26-000028.md) | [124](/filings/0001057877-25-000037.md) | [177 d](/filings/0001057877-25-000067.md) | [163 d](/filings/0001057877-26-000137.md) | [138 d](/filings/0001057877-26-000028.md) |
| Capital expenditure | $m | [118](/filings/0001057877-24-000027.md) | [156 d](/filings/0001057877-24-000041.md) | [153 d](/filings/0001057877-24-000047.md) | [184 d](/filings/0001057877-26-000028.md) | [260](/filings/0001057877-25-000037.md) | [346 d](/filings/0001057877-25-000067.md) | [218 d](/filings/0001057877-25-000082.md) | [185 d](/filings/0001057877-26-000028.md) | [201](/filings/0001057877-25-000037.md) | [333 d](/filings/0001057877-25-000067.md) | [291 d](/filings/0001057877-26-000137.md) | [354 d](/filings/0001057877-26-000028.md) |
| Dividends paid | $m | [40.5](/filings/0001057877-24-000027.md) | [40.0 d](/filings/0001057877-24-000041.md) | [40.0 d](/filings/0001057877-24-000047.md) | [43.0 d](/filings/0001057877-26-000028.md) | [42.7](/filings/0001057877-25-000037.md) | [42.1 d](/filings/0001057877-25-000067.md) | [44.3 d](/filings/0001057877-25-000082.md) | [47.4 d](/filings/0001057877-26-000028.md) | [46.9](/filings/0001057877-25-000037.md) | [46.5 d](/filings/0001057877-25-000067.md) | [46.5 d](/filings/0001057877-26-000137.md) | [48.5 d](/filings/0001057877-26-000028.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [50.7](/filings/0001057877-23-000045.md) | [50.7](/filings/0001057877-23-000059.md) | [50.7](/filings/0001057877-24-000027.md) | [50.8](/filings/0001057877-24-000041.md) | [50.8](/filings/0001057877-24-000047.md) | [50.8](/filings/0001057877-25-000037.md) | [52.2](/filings/0001057877-25-000067.md) | [53.5](/filings/0001057877-25-000082.md) | [54.1](/filings/0001057877-25-000037.md) | [54.4](/filings/0001057877-25-000067.md) | [55.1](/filings/0001057877-26-000137.md) | [58.7](/filings/0001057877-26-000137.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 58,887,379 at 2026-10-23, from the cover of the [10-Q filed 2026-10-29](/filings/0001057877-26-000137.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 08:05 ET. No prices; not investment advice.